Innovation Pharmaceuticals Inc (IPIX)

[Here Today]

The Last sentence of this paragraph from today’s Shareholder letter to ME puts the Companies on Notice that they are currently negotiating with for OM to either Shape Up and present a Strong offer or we will look elsewhere....

“We are engaged in licensing discussions with potential business partners for Brilacidin for the prevention of severe oral mucositis. In addition, we retained a prominent advisory company to help us with plans for this asset. We believe there is a tremendous unaddressed market that has the ability to generate billions of dollars in lifetime revenue for a company that can successfully develop a safe and highly efficacious, FDA-approved drug for OM. If we don’t receive an appropriate licensing offer, we will seek an internal pathway to begin advanced late stage clinical trials.”